ETCGX
Price
$45.00
Change
+$0.18 (+0.40%)
Updated
Jan 17 closing price
Net Assets
3.02B
RRMGX
Price
$90.18
Change
+$0.33 (+0.37%)
Updated
Jan 17 closing price
Net Assets
30.69B
Ad is loading...

ETCGX vs RRMGX

Header iconETCGX vs RRMGX Comparison
Open Charts ETCGX vs RRMGXBanner chart's image
Eventide Gilead C
Price$45.00
Change+$0.18 (+0.40%)
VolumeN/A
Net Assets3.02B
T. Rowe Price Mid-Cap Growth R
Price$90.18
Change+$0.33 (+0.37%)
VolumeN/A
Net Assets30.69B
ETCGX vs RRMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETCGX vs. RRMGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETCGX is a Hold and RRMGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 30.7B vs. ETCGX (3.02B). ETCGX (0.00) and RRMGX (0.00) have matching dividends . ETCGX was incepted earlier than RRMGX: ETCGX (15 years) vs RRMGX (22 years). ETCGX is a more actively managed with annual turnover of: 34.00 vs. RRMGX (21.70). ETCGX has a lower initial minimum investment than RRMGX: ETCGX (1000) vs RRMGX (2500). ETCGX annual gain was more profitable for investors over the last year : 4.75 vs. RRMGX (1.36). ETCGX return over 5 years is better than : 14.65 vs. RRMGX (-1.57).
ETCGXRRMGXETCGX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years22 years-
Gain YTD4.9202.571191%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets3.02B30.7B10%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.751.36349%
Returns for 3 years-9.77-6.88142%
Returns for 5 years14.65-1.57-932%
Returns for 10 years80.6527.05298%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAY69.62-0.56
-0.80%
Dayforce
HUMA4.41-0.07
-1.56%
Humacyte
TIXT3.55-0.09
-2.47%
TELUS International (Cda)
TCBP0.38-0.01
-3.61%
TC BioPharm (Holdings) plc
RENB0.71-0.04
-5.73%
Renovaro